Clinical Trial Update: A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating brepocitinib in adults with lichen planopilaris is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lichen Planopilaris

Drugs mentioned

• Brepocitinib (brepocitinib)

Snippet

Sponsor: Priovant Therapeutics, Inc. | Conditions: Lichen Planopilaris | Phase 2, Phase 3 | Status: RECRUITING